NeuroPace to Participate in Upcoming Healthcare Conferences
NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will participate in two healthcare...
Business Wire·14d ago
More News
NeuroPace, Inc. (NPCE) Reports Q2 Loss, Beats Revenue Estimates
NeuroPace (NPCE) delivered earnings and revenue surprises of -8.33% and +0.75%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
Stereotaxis Inc. (STXS) Reports Q2 Loss, Tops Revenue Estimates
Stereotaxis (STXS) delivered earnings and revenue surprises of +28.57% and +10.67%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PROCEPT BioRobotics (PRCT) delivered earnings and revenue surprises of +14.63% and -0.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
Orthofix (OFIX) Q2 Earnings and Revenues Beat Estimates
Orthofix (OFIX) delivered earnings and revenue surprises of +225.00% and +3.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AngioDynamics (ANGO) delivered earnings and revenue surprises of +76.92% and +7.52%, respectively, for the quarter ended May 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
NPCE Stock Tumbles Despite Positive One-Year Data From NAUTILUS Trial
Zacks·4mo ago
5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil
Zacks·4mo ago
NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates
Zacks·4mo ago
Recent Price Trend in NeuroPace (NPCE) is Your Friend, Here's Why